Literature DB >> 9099716

Human acetyl-CoA carboxylase 2. Molecular cloning, characterization, chromosomal mapping, and evidence for two isoforms.

L Abu-Elheiga1, D B Almarza-Ortega, A Baldini, S J Wakil.   

Abstract

cDNA encoding the 280-kDa acetyl-CoA carboxylase 2 (ACC2) isoform was isolated from human liver using the polymerase chain reaction. Sequencing the cDNA revealed an open reading frame of 7,449 base pairs (bp) that encode 2,483 amino acids (Mr 279,380). Using 5-kilobase pair cDNA clones as probes, we localized the gene encoding the 280-kDa human carboxylase to chromosome 12q23. When the cDNA of ACC2 was compared with that of ACC1, the nucleotide sequences and the predicted amino acid sequences had about 60 and 80% identity, respectively. Ser77 and Ser79, which were found to be critical for the phosphorylation and subsequent inactivation of rat ACC1 (Ser78 and Ser80 of human ACC1), are conserved in ACC2 and are represented as Ser219 and Ser221, respectively. On the other hand, Ser1200, which is also a phosphorylation site in rat ACC1 (Ser1201 of human ACC1), is not conserved in ACC2. The homology between the amino acid sequences of the two human carboxylases, however, is primarily found downstream of residues Ser78 and Ser81 in human ACC1 and their equivalents, that is Ser219 and Ser221 in ACC2, suggesting that the sequence of the first 218 amino acids at the N terminus of ACC2 represents a unique peptide that accounts, in part, for the variance between the two carboxylases. Using a cDNA probe (400 bp) that encodes the N-terminal amino acid residues of ACC2 in Northern blot analyses of different human and mouse tissues showed that ACC2 is predominantly expressed in liver, heart, and the skeletal muscles. Polyclonal antibodies raised against the N-terminal peptide (amino acid residues 1-220) reacted specifically and equally with human and rat ACC2 carboxylases, confirming the uniqueness of this N-terminal peptide and its conservation in animal ACC2. In addition, we present evidence for the presence of an isoform of ACC2 (Mr 270,000) in human liver that differs from the 280-kDa ACC2 by the absence of 303 nucleotides that encode 101 amino acids in the region between Arg1114 and Asp1215. The regulation and physiological significance of the two ACC2 isoforms remain to be determined.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9099716     DOI: 10.1074/jbc.272.16.10669

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Structure-guided inhibitor design for human acetyl-coenzyme A carboxylase by interspecies active site conversion.

Authors:  Francis Rajamohan; Eric Marr; Allan R Reyes; James A Landro; Marie D Anderson; Jeffrey W Corbett; Kenneth J Dirico; James H Harwood; Meihua Tu; Felix F Vajdos
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

Review 2.  Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome.

Authors:  Jun Kusunoki; Akio Kanatani; David E Moller
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Cellular expression of a monocarboxylate transporter (MCT1) in the mammary gland and sebaceous gland of mice.

Authors:  Kumiko Takebe; Junko Nio-Kobayashi; Hiromi Takahashi-Iwanaga; Takaji Yajima; Toshihiko Iwanaga
Journal:  Histochem Cell Biol       Date:  2008-12-02       Impact factor: 4.304

4.  The human ACC2 CT-domain C-terminus is required for full functionality and has a novel twist.

Authors:  Kevin P Madauss; William A Burkhart; Thomas G Consler; David J Cowan; William K Gottschalk; Aaron B Miller; Steven A Short; Thuy B Tran; Shawn P Williams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-04-18

5.  PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2.

Authors:  Natalie J German; Haejin Yoon; Rushdia Z Yusuf; J Patrick Murphy; Lydia W S Finley; Gaëlle Laurent; Wilhelm Haas; F Kyle Satterstrom; Jlenia Guarnerio; Elma Zaganjor; Daniel Santos; Pier Paolo Pandolfi; Andrew H Beck; Steven P Gygi; David T Scadden; William G Kaelin; Marcia C Haigis
Journal:  Mol Cell       Date:  2016-09-15       Impact factor: 17.970

6.  Acetyl-CoA carboxylase 2-/- mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions.

Authors:  Lutfi Abu-Elheiga; Hongmei Wu; Ziwei Gu; Rubin Bressler; Salih J Wakil
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

7.  Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal.

Authors:  Lutfi Abu-Elheiga; Martin M Matzuk; Parichher Kordari; WonKeun Oh; Tattym Shaikenov; Ziwei Gu; Salih J Wakil
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

Review 8.  Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β.

Authors:  Simon Ducheix; Maria Carmela Vegliante; Gaetano Villani; Nicola Napoli; Carlo Sabbà; Antonio Moschetta
Journal:  Cell Mol Life Sci       Date:  2016-08-13       Impact factor: 9.261

9.  Comparative Approach of the de novo Fatty Acid Synthesis (Lipogenesis) between Ruminant and Non Ruminant Mammalian Species: From Biochemical Level to the Main Regulatory Lipogenic Genes.

Authors:  G P Laliotis; I Bizelis; E Rogdakis
Journal:  Curr Genomics       Date:  2010-05       Impact factor: 2.236

10.  A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes.

Authors:  Shiro Maeda; Masa-aki Kobayashi; Shin-ichi Araki; Tetsuya Babazono; Barry I Freedman; Meredith A Bostrom; Jessica N Cooke; Masao Toyoda; Tomoya Umezono; Lise Tarnow; Torben Hansen; Peter Gaede; Anders Jorsal; Daniel P K Ng; Minoru Ikeda; Toru Yanagimoto; Tatsuhiko Tsunoda; Hiroyuki Unoki; Koichi Kawai; Masahito Imanishi; Daisuke Suzuki; Hyoung Doo Shin; Kyong Soo Park; Atsunori Kashiwagi; Yasuhiko Iwamoto; Kohei Kaku; Ryuzo Kawamori; Hans-Henrik Parving; Donald W Bowden; Oluf Pedersen; Yusuke Nakamura
Journal:  PLoS Genet       Date:  2010-02-12       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.